Puris, E., Petralla, S., Auriola, S., Kidron, H., Fricker, G., & Gynther, M. (2023). Monoacylglycerol lipase inhibitor JJKK048 ameliorates ABCG2 transporter-mediated regorafenib resistance induced by hypoxia in triple negative breast cancer cells. Journal of pharmaceutical sciences, 112(9), . https://doi.org/10.1016/j.xphs.2023.05.012
Chicago-Zitierstil (17. Ausg.)Puris, Elena, Sabrina Petralla, Seppo Auriola, Heidi Kidron, Gert Fricker, und Mikko Gynther. "Monoacylglycerol Lipase Inhibitor JJKK048 Ameliorates ABCG2 Transporter-mediated Regorafenib Resistance Induced by Hypoxia in Triple Negative Breast Cancer Cells." Journal of Pharmaceutical Sciences 112, no. 9 (2023). https://doi.org/10.1016/j.xphs.2023.05.012.
MLA-Zitierstil (9. Ausg.)Puris, Elena, et al. "Monoacylglycerol Lipase Inhibitor JJKK048 Ameliorates ABCG2 Transporter-mediated Regorafenib Resistance Induced by Hypoxia in Triple Negative Breast Cancer Cells." Journal of Pharmaceutical Sciences, vol. 112, no. 9, 2023, https://doi.org/10.1016/j.xphs.2023.05.012.